PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · Journal of Coloproctology 2021; 41(03): 234-241
DOI: 10.1055/s-0041-1735544
Original Article

Selective Hemorrhoidal Dearterialization with High Mucopexy in the Surgical Treatment of Hemorrhoidal Disease

Carlos Mateus Rotta 
1   Departament of Coloproctology, Faculty of Medicine, Universidade de Mogi das Cruzes, Mogi das Cruzes, SP, Brazil
,
Stephanie Drago 
2   Medical school, Universidade de Mogi das Cruzes, Mogi das Cruzes, SP, Brazil
,
Afonso Henrique da Silva e Sousa  Jr
3   Department of Surgery, Universidade de São Paulo, São Paulo, SP, Brazil
,
Carlos Augusto Real Martinez 
4   Graduate Studies in Health Sciences, Universidade de São Francisco, Bragança Paulista, SP, Brazil
5   Department of Surgery, Faculty of Medical Sciences, Universidade Estadual de Campinas, Campinas, SP, Brazil
,
Marjorie Cristina da Cruz Bernardino 
6   Statistics, Universidade de Mogi das Cruzes, Mogi das Cruzes, SP, Brazil
› Author Affiliations
Source of funding None.
› Further Information
Also available ateRef
  Permissions and Reprints
Preview

Abstract

The doppler-guided transanal hemorrhoidal dearterialization technique associated with mucopexy is a noninvasive surgical option used to treat hemorrhoidal disease (HD).

Objective To compare and analyze the results using a variation of the doppler-guided transanal hemorrhoidal dearterialization technique with the technique of selective hemorrhoidal dearterialization with high mucopexy in the treatment of HD.

Method A total of 292 patients who underwent surgical treatment for grade II, III and IV HD from March 2012 to December 2017 were studied. From this total, 110 (37.6%) patients underwent a conventional doppler-guided transanal hemorrhoidal dearterialization with mucopexy (CD), and 182 (62.3%) underwent selective hemorrhoidal dearterialization with high mucopexy (SHeLF). In the group of patients undergoing CD, 4 patients (3.64%) had grade II HD, 82 (74.55%) grade III, and 24 (21.82%) grade IV. In the group submitted to SHeLF, 18 (9.89%) patients had grade II HD, 86 (47.25%) had grade III, and 65 (35.71%) had grade IV. The same surgeon operated all patients under spinal anesthesia. In patients undergoing CD, six arterial branches have been dearterialized, while in patients undergoing SHeLF, the hemorrhoidary nipples submitted to a dearterialization were selected (from 1 to 5) by intraoperative evaluation followed by high rectal mucopexy. In the postoperative period, the following parameters were evaluated: pain, tenesmus, bleeding, and recurrence.

Moderate results to severe pain was a postoperative complaint reported by 13 (11.82%) patients undergoing CD, and by 19 (10.44%) undergoing SHeLF. Intense tenesmus was reported by 26 (23.64%) patients undergoing CD and by 7 (3.85%) undergoing SHeLF. Three patients (2.73%) undergoing CD and 1 (0.55%) undergoing SHeLF evolved with postoperative bleeding. One patient (0.55%) in the group undergoing CD required surgical review of hemostasis. Six patients (5.45%) who underwent CD and 8 (4.39%) who underwent SHeLF were reoperated due to disease recurrence.

Conclusion Comparing statistics, patients undergoing the SHeLF technique have less postoperative pain, tenesmus and postoperative bleeding when compared with CD.

Keywords

hemorrhoids - hemorrhoids/surgery - hemorrhoidectomy - ligation - ultrasonography - doppler - pulsed - transanal endoscopic surgery

2 Sanofi-Aventis Farmacêutica Ltda., Suzano, São Paulo, Brazil.




Publication History

Received: 05 January 2021

Accepted: 15 June 2021

Article published online:
20 September 2021

© 2021. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil